2024 annual financial data
Lakefront Biotherapeutics 2024 Net margin
Direct answer
Net margin was 26.88%.
Operating income was -188,338,000 EUR and net income was 74,082,000 EUR.
Operating cash flow was -320,026,000 EUR.
Get free Lakefront Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 275,649,000 EUR
- Operating income
- -188,338,000 EUR
- Net income
- 74,082,000 EUR
- Operating cash flow
- -320,026,000 EUR
Explore related company data
View all 2024 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Lakefront Biotherapeutics financial years